BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19879135)

  • 1. Synthesis and biological evaluation of 2-amino-7,7-dimethyl 4-substituted-5-oxo-1-(3,4,5-trimethoxy)-1,4,5,6,7,8-hexahydro-quinoline-3-carbonitrile derivatives as potential cytotoxic agents.
    Alqasoumi SI; Al-Taweel AM; Alafeefy AM; Hamed MM; Noaman E; Ghorab MM
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6939-42. PubMed ID: 19879135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors.
    Nien CY; Chen YC; Kuo CC; Hsieh HP; Chang CY; Wu JS; Wu SY; Liou JP; Chang JY
    J Med Chem; 2010 Mar; 53(5):2309-13. PubMed ID: 20148562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
    Ghorab MM; Ragab FA; Hamed MM
    Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro anticancer evaluation of some novel hexahydroquinoline derivatives having a benzenesulfonamide moiety.
    Al-Said MS; Ghorab MM; Al-Dosari MS; Hamed MM
    Eur J Med Chem; 2011 Jan; 46(1):201-7. PubMed ID: 21112675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety.
    Ghorab MM; Ragab FA; Heiba HI; Arafa RK; El-Hossary EM
    Eur J Med Chem; 2010 Sep; 45(9):3677-84. PubMed ID: 20684857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, molecular modeling and biological evaluation of guanidine derivatives as novel antitubulin agents.
    Qian Y; Zhang HJ; Lv PC; Zhu HL
    Bioorg Med Chem; 2010 Dec; 18(23):8218-25. PubMed ID: 21036623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 7-oxo-7H-naphtho[1,2,3-de]quinoline derivatives as potential anticancer agents active on multidrug resistant cell lines.
    Dzieduszycka M; Bontemps-Gracz MM; Stefańska B; Martelli S; Piwkowska A; Arciemiuk M; Borowski E
    Bioorg Med Chem; 2006 May; 14(9):2880-6. PubMed ID: 16458007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. Part 1: Structure-activity relationships of the 1- and 3-positions.
    Kemnitzer W; Kuemmerle J; Jiang S; Zhang HZ; Sirisoma N; Kasibhatla S; Crogan-Grundy C; Tseng B; Drewe J; Cai SX
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6259-64. PubMed ID: 18952423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as potent Src kinase inhibitors.
    Berger DM; Dutia M; Birnberg G; Powell D; Boschelli DH; Wang YD; Ravi M; Yaczko D; Golas J; Lucas J; Boschelli F
    J Med Chem; 2005 Sep; 48(19):5909-20. PubMed ID: 16161995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity.
    Tsou HR; Overbeek-Klumpers EG; Hallett WA; Reich MF; Floyd MB; Johnson BD; Michalak RS; Nilakantan R; Discafani C; Golas J; Rabindran SK; Shen R; Shi X; Wang YF; Upeslacis J; Wissner A
    J Med Chem; 2005 Feb; 48(4):1107-31. PubMed ID: 15715478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
    Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
    J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel quinolines bearing a biologically active trimethoxyphenyl moiety as a new class of antitumor agents.
    Al-Said MS; Bashandy MS; Ghorab MM
    Arzneimittelforschung; 2011; 61(9):527-31. PubMed ID: 22029230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and SAR of C12-C13-oxazoline derivatives of epothilone A.
    Pfeiffer B; Hauenstein K; Merz P; Gertsch J; Altmann KH
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3760-3. PubMed ID: 19433359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
    Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY
    J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
    Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R
    J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumor-evaluation of cyclopropyl-containing combretastatin analogs.
    Fürst R; Zupkó I; Berényi A; Ecker GF; Rinner U
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6948-51. PubMed ID: 19879758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of quinoline analogues of flavones as potential anticancer agents and tubulin polymerization inhibitors.
    Shobeiri N; Rashedi M; Mosaffa F; Zarghi A; Ghandadi M; Ghasemi A; Ghodsi R
    Eur J Med Chem; 2016 May; 114():14-23. PubMed ID: 26974371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and docking studies of some novel quinoline derivatives bearing a sulfonamide moiety as possible anticancer agents.
    Ghorab MM; Ragab FA; Hamed MM
    Arzneimittelforschung; 2010; 60(3):141-8. PubMed ID: 20422946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzopyridooxathiazepine derivatives as novel potent antimitotic agents.
    Gallet S; Flouquet N; Carato P; Pfeiffer B; Renard P; Léonce S; Pierré A; Berthelot P; Lebegue N
    Bioorg Med Chem; 2009 Feb; 17(3):1132-8. PubMed ID: 19162484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agents.
    Leese MP; Jourdan FL; Gaukroger K; Mahon MF; Newman SP; Foster PA; Stengel C; Regis-Lydi S; Ferrandis E; Di Fiore A; De Simone G; Supuran CT; Purohit A; Reed MJ; Potter BV
    J Med Chem; 2008 Mar; 51(5):1295-308. PubMed ID: 18260615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.